Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas

Ricardo Rivera-Soto(University of North Carolina at Chapel Hill), Blossom Damania(UNC Lineberger Comprehensive Cancer Center)
Frontiers in Oncology
June 18, 2021
Cited by 13


Related Papers